Market Signal Briefing

Vontier Corporation (NYSE:VNT) Shareholder/Analyst Call October 15, 2025 9:00 AM EDT

Company Participants

Ryan Edelman - Vice President of Investor Relations
Mark Morelli - President, CEO & Director
Mark Williams
Andrew Bennett
Devon Watson
Austin Lieb
Andrew Bennet
Anshooman Aga - Senior VP & CFO
Elaine Kanak

Conference Call Participants

Julian Mitchell - Barclays Bank PLC, Research Division
Tracy Long
Dan Munford
Elaine Mohr
Nigel Coe - Wolfe Research, LLC
Robert Mason - Robert W. Baird & Co. Incorporated, Research Division
Katie Fleischer - KeyBanc Capital Markets Inc., Research Division

Conversation

Ryan Edelman
Vice President of Investor Relations

All right. Good morning, everybody. We're going to go ahead and get started here. So, first off, I want to say thank you to everyone who could be here with us in Chicago today, and thank you to those of you listening on the webcast. We know it's a busy time for all of you, so we appreciate your interest in Vontier, and we appreciate you taking the time today.

So just to give you a little lay of the land, we're here at NACS, which is the National Association of Convenience Stores, largest annual trade show of the year. It's sort of a massive show, a lot of excitement going on, a lot of folks here. But we wanted to bring you here just in an effort to help address a lot of your questions. We get a lot of questions, Mark, Anshooman and I when we're with you around the businesses, how they come together and just broadly more detail about the convenience retail end market. So we're hopefully going to spend a lot of time on that today. And our intent is to really help educate you here on this end market. We want to give you a better understanding of our strategic vision. We want to share with you our conviction for the growth drivers in this end market and how we're creating significant opportunities and

Recommended For You

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Semler Scientific, Inc. (NASDAQ: SMLR) between March 10, 2021 and April 15, 2025, both dates inclusive (the “Class Period”), of the important October 28, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased Semler Scientific securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Semler Scientific class action, go to https://rosenlegal.com/submit-form/?case_id=39889 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) Semler Scientific did not disclose a material investigation by the United States Department of Justice (the "DOJ") into violations of the False Claims Act, while discussing possible violations of the False Claims Act (and aggressive DOJ enforcement thereof) in hypothetical terms; and (2) as a result, defendants' public statements were materially false and/or misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Semler Scientific class action, go to https://rosenlegal.com/submit-form/?case_id=39889 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW ORLEANS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 28, 2025 to file lead plaintiff applications in a securities class action lawsuit against Dow Inc. (NYSE: DOW), if they purchased the Company’s securities between January 30, 2025 and July 23, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of Michigan.

Get Help

Dow investors should visit us at https://claimsfiler.com/cases/nyse-dow-1/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Dow and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On July 24, 2025, the Company disclosed a 2Q 2025 non-GAAP loss per share of $0.42, much larger than the approximate $0.17 to $0.18 per share loss expected by analysts, and net sales of $10.1 billion, representing a 7.3% year-over-year decline and missing consensus estimates by $130 million, “reflecting declines in all operating segments” due in part to “the lower-for-longer earnings environment that our industry is facing, amplified by recent trade and tariff uncertainties.” Further, the Company disclosed that it was cutting its dividend in half, from $0.70 per share to only $0.35 per share, citing the need for “financial flexibility amidst a persistently challenging macroeconomic environment.”

On this news, the price of Dow’s shares fell $5.30 per share, or 17.45%, to close at $25.07 per share on July 24, 2025.  

The case is Sarti v. Dow Inc., No. 25-cv-12744.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of National Grid plc (NYSE: NGG) resulting from allegations that National Grid plc may have issued materially misleading business information to the investing public.

SO WHAT: If you purchased National Grid securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=41344 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

WHAT IS THIS ABOUT: On July 2, 2025, Reuters published an article entitled “‘Preventable’ National Grid failures led to Heathrow fire, findings say.” The article stated that a “fire that shut London’s Heathrow airport in March, stranding thousands of people, was caused by the UK power grid’s failure to maintain an electricity substation, an official report said on Wednesday, prompting the energy watchdog to open a probe.” Further, the article stated that the United Kingdom’s Energy minister, Ed Miliband, had “called the report “deeply concerning”, after it concluded that the issue which caused the fire was identified seven years ago but went unaddressed by power grid operator National Grid[.]”

On this news, National Grid’s American Depositary Shares (“ADSs”) fell 5%, on July 2, 2024.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW ORLEANS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 18, 2025 to file lead plaintiff applications in a securities class action lawsuit against KBR, Inc. (NYSE: KBR), if they purchased or otherwise acquired the Company’s securities between May 6, 2025 and June 19, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of Texas.

Get Help

KBR investors should visit us at https://www.claimsfiler.com/cases/nyse-kbr-1 or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

KBR and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On June 19, 2025, HomeSafe Alliance (“HomeSafe”), a KBR joint venture in which KBR has a 72% economic interest, disclosed that it received “a notice from the U.S. Department of Defense's Transportation Command (TRANSCOM) terminating the Global Household Goods Contract, which HomeSafe won in 2021 to transform the military move system for the benefit of service members and their families.”

On this news, the price of KBR’s shares fell $3.85 per share, or 7.29%, to close at $48.93 on June 20, 2025. On June 23, 2025, the next trading day, KBR stock fell a further $1.30, or 2.65%, to close at $47.63 on June 23, 2025.

The case is Norrman v. KBR, Inc., et al., No. 25-cv-04464.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

NEW ORLEANS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 2, 2025 to file lead plaintiff applications in a securities class action lawsuit against Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH), if they purchased or otherwise acquired the Company’s securities between February 5, 2025 and July 23, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.

Get Help

Molina Healthcare investors should visit us at https://claimsfiler.com/cases/nyse-moh-2/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Molina Healthcare and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On July 23, 2025, the Company reported its financial results for the second quarter ended June 30, 2025 and cut its full-year 2025 earnings guidance, disclosing that “GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year” and it “now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share,” due to a “challenging medical cost trend environment,” including “utilization of behavioral health, pharmacy, and inpatient and outpatient services.”

On this news, the price of Molina’s shares fell $32.03, or 16.84%, to close at $158.22 per share on July 24, 2025, on unusually heavy trading volume.

The case is Hindlemann v. Molina Healthcare, Inc., et al., No. 2:25-cv-09461.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

NEW ORLEANS, Oct. 15, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until December 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Marex Group plc (“Marex” or the “Company”) (NasdaqGS: MRX), if they purchased or otherwise acquired the Company’s securities between May 16, 2024 and August 5, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

Get Help

Marex investors should visit us at https://claimsfiler.com/cases/nasdaq-mrx/ or call toll-free (844) 367-9658. Lawyers at Kahn Swick & Foti, LLC are available to discuss your legal options.

About the Lawsuit

Marex and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On August 5, 2025, NINGI Research reported numerous allegations about the Company including, among other things, that it “has engaged in a multi-year accounting scheme involving a web of opaque off-balance-sheet entities, fictitious intercompany transactions, and misleading disclosures to conceal significant losses, inflate profits, and mask its true risk exposure” and that it has “numerous multi-million-dollar discrepancies in intercompany receivables and loans across Marex’s sprawling network of 56+ entities.” The report further identified “a $17 million receivable created out of thin air, a subsidiary whose reported profit was inflated by 150% in group filings before being liquidated, and an asset valued at $14.9 million that was sold to Robinhood for just $2.5 million weeks later, with no reported loss” and that the Company concealed nearly $1 billion in off-balance-sheet derivatives exposure through a Luxembourg fund it both controls and trades with, and that it is using the fund to generate non-cash trading profits and inflate operating cash flow by misclassifying structured note issuance as income.

On this news, the price of Marex’s shares fell $2.33, or 6.2%, to close at $35.31 per share on August 5, 2025, on unusually heavy trading volume.

The case is Narayanan v. Marex Group PLC, et al., No. 25-cv-08393.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. At ClaimsFiler.com, investors can: (1) register for free to gain access to information and settlement websites for various securities class action cases so they can timely submit their own claims; (2) upload their portfolio transactional data to be notified about relevant securities cases in which they may have a financial interest; and (3) submit inquiries to the Kahn Swick & Foti, LLC law firm for free case evaluations.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE: SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Snap securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Snap class action, go to https://rosenlegal.com/submit-form/?case_id=2663 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 20, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period created the false impression that they possessed reliable information pertaining to Snap’s expected advertising revenue and anticipated growth while emphasizing potential macroeconomic instability. In truth, Snap’s optimistic reports of advertising growth and earnings potential fell short of reality as they relied far too heavily on Snap’s ability to execute on its potential; Snap was already experiencing the ramifications of a significant execution error when defendants’ claimed a lack of visibility due to macroeconomic conditions. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Snap class action, go to https://rosenlegal.com/submit-form/?case_id=2663 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in SNOW over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

LOS ANGELES--(BUSINESS WIRE)--Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – LRMR.

Chief Financial Officers now play a critical role in shaping corporate strategy and positioning organizations to meet future challenges. This episode profiles CFO Natasha Fernandes of IMAX.

October 15, 2025 9:42 PM EDT | Source: American Critical Minerals Corp.
Vancouver, British Columbia--(Newsfile Corp. - October 15, 2025) - American Critical Minerals Corp. (CSE: KCLI) (OTCQB: APCOF) (FSE: 2P30) ("American Critical Minerals" or the "Company") is pleased to announce that it has entered into an agreement with Research Capital Corporation as the sole underwriter and sole bookrunner, (the "Underwriter"), pursuant to which the Underwriter has agreed to purchase, on a bought deal basis, 11,429,000 units of the Company (the "Units") at a price of $0.35 per Unit (the "Offering Price") for aggregate gross proceeds to the Company of $4,000,150 (the "Offering").

In addition, the Company is also pleased to announce a concurrent non-brokered private placement of up to 5,714,286 Units at a price of $0.35 per Unit for gross proceeds of up to $2,000,000 (the "Non-Brokered Private Placement"). Together with the Offering and the Non-Brokered Private Placement, the Company expects to raise aggregate gross proceeds of up to $6,000,000.

Each Unit shall be comprised of one common share of the Company (a "Common Share") and one-half of one Common Share purchase warrant of the Company (each whole warrant, a "Warrant"). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.45 per Common Share for a period of 36 months following closing of the Offering, provided that holders will not be permitted to exercise Warrants until 60 days following closing of the Offering.

The net proceeds from the Offering of the Units will be used for working capital and general corporate purposes.

The Company has granted to the Underwriter an option (the "Underwriters' Option") to increase the size of the Offering by up to an additional number of Units, that in aggregate would be equal to 15% of the total number of Units to be issued under the Offering, exercisable at any time up to 48 hours prior to the closing of the Offering.

The Units to be issued under the Offering and the Non-Brokered Private Placement will be offered for sale pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as amended by CSA Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (collectively, the "Listed Issuer Financing Exemption"), in all provinces of Canada, except Quebec, and other qualifying jurisdictions, including the United States. The Units offered under the Listed Issuer Financing Exemption will be immediately "free-trading" under applicable Canadian securities laws.

There is an offering document (the "Offering Document") related to this Offering and Non-Brokered Private Placement that can be accessed under the Company's profile at www.sedarplus.ca and at the Company's website at www.acmineralscorp.com. Prospective investors should read this Offering Document before making an investment decision.

The closing of the Offering and the Non-Brokered Private Placement are expected to occur on or about the week of October 27, 2025 (the "Closing"), or such other earlier or later date as the Underwriter may determine. Closing is subject to the Company receiving all necessary regulatory approvals, including the conditional approval of the Canadian Securities Exchange.

The Underwriter will receive a cash commission of 7.0% of the aggregate gross proceeds of the Offering and such number of broker warrants (the "Broker Warrants") as is equal to 7.0% of the number of Units sold under the Offering. Each Broker Warrant entitles the holder to purchase one Unit at an exercise price equal to the Offering Price for a period of 36 months following the Closing.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About American Critical Minerals' Green River Potash and Lithium Project

The Green River Potash and Lithium Project is situated within Utah's highly productive Paradox Basin, located 20 miles northwest of Moab, Utah and has significant logistical advantages including close proximity to major rail hubs, airport, roads, water, towns and labour markets. It also benefits from close proximity to the agricultural and industrial heartland of America and numerous potential end-users for its products.

The history of oil and gas production across the Paradox Basin provides geologic data from historic wells across the Project, and the wider Basin, validating and de-risking the potential for high grade potash and large amounts of contained lithium. Wells in and around the project reported lithium up to 500 ppm, bromine up to 6,100 ppm and boron up to 1,260 ppm (Gilbride & Santos, 2012). This data is reinforced by nearby potash production and the advanced stage of neighbouring lithium projects. The Paradox Basin is believed to contain up to 56 billion tonnes of lithium brines, potentially the largest such resource in US (Source: Anson Fastmarkets Presentation – https://wcsecure.weblink.com.au/pdf/ASN/02823465.pdf) The Company also has a 43-101 Exploration Target of 600 million to 1 billion tonnes of sylvinite (the most important source for the production of potash in North America) with average grades ranging from 19% to 29% KCL.**

The Company holds a 100% interest in eleven State of Utah ("SITLA") mineral and minerals salt leases covering approximately 7,050 acres, 1,094 federal lithium brine claims (BLM Placer Claims) covering 21,150 acres, and 11 federal (BLM) potash prospecting permits covering approximately 25,480 acres. Through these leases, permits and claims the Company has the ability to explore for potash, lithium and potential by-products across the entire Green River Project (approx. 32,530 acres). The Company is authorized to drill a total of 7 drill holes across the Project (pending bonding the recently approved 4 drill holes).

Intrepid Potash, Inc. is America's largest potash company and only U.S. domestic potash producer and currently produces potash from its nearby Moab Solution Mine, which the Company believes provides strong evidence of stratigraphic continuity within this part of the Paradox Basin (www.intrepidpotash.com). Anson Resources Ltd. has advanced lithium development projects contiguous to the northern boundary of our Green River Project and neighbouring to the south. Anson has a large initial resource, robust definitive feasibility study and has recently completed successful piloting operations through its partnership with Koch Technology Solutions, as well as an offtake agreement with LG Energy Solution. The Anson exploration targets encompass the combined Mississippian Leadville Formation and the Pennsylvanian Paradox Formation brine-bearing clastic layers, which also underlie American Critical Minerals' entire project area (www.ansonresources.com)*.

In 2022, the U.S. imported approx. 96.5% of its annual potash requirements with domestic producers receiving a higher sales price due to proximity to market (intrepidpotash.com/ August 15, 2024, Investor Presentation). In March 2024, the US Senate introduced a bill to include key fertilizers and potash on the US Department of Interior list of Critical Minerals which already includes lithium, and this process is well advanced with potash being added to the USGS Draft Critical Minerals List. In August 2025. Recent market estimates suggest that the global potash market is over US$50 billion annually and growing at a compound annual growth rate ("CAGR") of close to 5%. Annual lithium demand is now estimated to be over 1 million tonnes globally and continuing to grow rapidly. * **

*American Critical Minerals' management cautions that results or discoveries on properties in proximity to the American Critical Minerals' properties may not necessarily be indicative of the presence of mineralization on the Company's properties.

**A report titled "NI 43-101 Technical Report - Green River Potash Project, Grand County, Utah, USA", prepared by Agapito Associates Inc., and dated effective September 12, 2012, quantifies the Green River Potash Project's potash exploration potential in the form of a NI 43-101 Exploration Target. The Exploration Target estimate was prepared in accordance with the National Instrument 43-101 –Standards of Disclosure for Mineral Projects ("NI 43-101"). It should be noted that Exploration Targets are conceptual in nature and there has been insufficient exploration to define them as Mineral Resources, and, while reasonable potential may exist, it is uncertain whether further exploration will result in the determination of a Mineral Resource under NI 43-101. The Exploration Target stated in the Agapito Report is not being reported as part of any Mineral Resource or Mineral Reserve. A copy of the report can be accessed on the corporate website for the Company: www.acmineralscorp.com.

***United States Geological Survey, Mineral Commodity Summaries, January 2024 (https://pubs.usgs.gov/periodicals/mcs2024/mcs2024-potash.pdf).

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains forward-looking information within the meaning of applicable securities legislation. Forward-looking information is typically identified by words such as: believe, uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. Important factors that could cause actual results to differ from this forward-looking information include those described under the heading "Risks and Uncertainties" in the Company's most recently filed MD&A. The Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. Readers are cautioned not to place undue reliance on forward-looking expect, anticipate, intend, estimate, postulate and similar expressions, or are those, which, by their nature, refer to future events. Such statements include, without limitation, statements regarding the intended use of proceeds from the Offering. Although the Company believes that such statements are reasonable, it can give no assurances that such expectations will prove to be correct. All such forward-looking information is based on certain assumptions and analyses made by the Company in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. This information, however, is subject to a variety of risks and information.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/270645

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of LifeMD, Inc. (NASDAQ: LFMD) between May 7, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), of the important October 27, 2025 lead plaintiff deadline in the securities class action first filed by the Firm.

SO WHAT: If you purchased LifeMD securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the LifeMD class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 27, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) defendants materially overstated LifeMD’s competitive position; (2) defendants were reckless in raising LifeMD’s 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD’s RexMD segment, as well as for customer acquisition costs related to the sale of drugs designed to treat obesity, including Wegovy and Zepbound; and (3) as a result, defendants’ statements about LifeMD’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the LifeMD class action, go to https://rosenlegal.com/submit-form/?case_id=43404 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

LOS ANGELES--(BUSINESS WIRE)--America's Car-Mart, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – CRMT.

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Tronox Holdings plc (NYSE: TROX) between February 12, 2025 and July 30, 2025, both dates inclusive (the “Class Period”), of the important November 3, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Tronox common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Tronox class action, go to https://rosenlegal.com/submit-form/?case_id=44403 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 3, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made statements regarding Tronox’s overall expected growth and strength in its pigment and zircon commercial division. The lawsuit alleges that defendants made overwhelmingly positive statements to investors regarding these divisions, as well as on its ability to achieve 2025 revenue growth projections, to investors while at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Tronox’s ability to forecast the demand for its pigment and zircon products or otherwise the true state of its commercial division, despite making lofty long-term projections, Tronox’s forecasting processes fell short as sales continued to decline and costs increased, ultimately, derailing Tronox’s revenue projections. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Tronox class action, go to https://rosenlegal.com/submit-form/?case_id=44403 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

NEW YORK, Oct. 15, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ: NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”), of the important October 21, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Nutex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Nutex class action, go to https://rosenlegal.com/submit-form/?case_id=43936 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) HaloMD, a third-party independent dispute resolution vendor (“IDR”), was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (2) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to Nutex’s engagement with HaloMD in the IDR process were unsustainable; (3) in addition, Nutex overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (4) as a result, Nutex was unable to effectively account for the treatment of certain of its stock based compensation obligations; (5) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (6) the foregoing increased the risk that Nutex would be unable to timely file certain financial reports with the SEC; (7) accordingly, Nutex’s business and/or financial prospects were overstated; and (8) as a result, defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Nutex class action, go to https://rosenlegal.com/submit-form/?case_id=43936 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

, /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock between March 10, 2024 and September 29, 2025. MoonLake is a Swiss clinical-stage biotechnology company focused on inflammatory diseases driven by interleukin-17 (IL-17), particularly in dermatology and rheumatology.

For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.

The Allegations: Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate  

According to the complaint, during the class period, defendants disclose material facts, regarding the distinction between the Nanobodies and monoclonal antibodies, including that: (1) that SLK (MoonLake's phase 2 drug) and BIMZELX (the FDA approved drug against which SLK would have to demonstrate superior efficacy) share the same molecular targets (the inflammatory cytokines IL-17A and IL-17F); (2) that SLK's distinct Nanobody structure would not confer a superior clinical benefit over the traditional monoclonal structure of BIMZELX; (3) SLK's distinct Nanobody structure supposed increased tissue penetration would not translate to clinical efficacy; and (4) based on the foregoing, defendants lacked a reasonable basis for their positive statements regarding SLK's purported superiority to monoclonal antibodies.

Plaintiff alleges that on September 28, 2025, MoonLake announced week-16 results from its Phase 3 VELA program. The results showed that SLK failed to demonstrate competitive efficacy relative to BIMZELX. Following the announcement, MoonLake's stock price cratered, falling $55.75 per share, or 89.9%, to close at $6.24 on September 29, 2025.

Next Steps: You may be eligible to participate in the class action against MoonLake Immunotherapeutics. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by December 15, 2025. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses. 

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. 

To be notified if a class action against MoonLake Immunotherapeutics settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising.  Past results do not guarantee a similar outcome.  

SOURCE Robbins LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Quantum computing and robotics represent the next frontiers of the artificial intelligence (AI) revolution.

Over the past three years, artificial intelligence (AI) has largely been deployed to train large language models (LLMs) and to build productivity-enhancing software for the workplace. But the next phase of AI's evolution extends well beyond chatbots or digital assistants.

Two trillion-dollar titans -- Nvidia (NVDA -0.17%) and Tesla (TSLA 1.39%) -- are spearheading AI's next frontiers: quantum computing and robotics.

As these "Magnificent Seven" powerhouses quietly develop next-generation AI systems, their efforts could redefine how humans and machines interact -- reshaping entire economies for decades to come.

Nvidia's ambition: Bridging classical and quantum worlds
Nvidia is no stranger to paradigm shifts. What began as a company building chips to enhance graphics for gamers has evolved into the backbone of the generative AI revolution. Over the past three years, the company's graphics processing units (GPUs) have powered the rise of models like ChatGPT, generating hundreds of billions in revenue and record-breaking profits.

Now, Nvidia has its sights set on an even larger opportunity: quantum AI -- a market some on Wall Street believe could one day reach $10 trillion. At the center of this push is CUDA-Q, Nvidia's quantum-classical computing architecture. By integrating quantum algorithms with its GPU infrastructure, the company is enabling hybrid workflows that bridge today's conventional AI systems with tomorrow's quantum breakthroughs.

This approach could prove transformative. In fields like pharmaceuticals, energy, and autonomous systems design, quantum-powered simulations could unlock solutions to problems long considered beyond reach -- from molecular drug discovery, advanced weather predictions, and reimagining city planning.

If successful, Nvidia won't just be a main character within the next chapter of the AI story, it could become the primary author writing the next era of computational science.

Tesla's robotics revolution: Why Optimus could be the company's next catalyst
While Nvidia is designing the hardware to make machines think faster, Tesla is focused on bringing them to life. Enter Optimus -- the humanoid robot that could revolutionize how the world views automation.

Optimus may be Tesla's most ambitious project yet: a bipedal robot capable of performing repetitive human tasks through the power of AI. It represents a fusion of robotics, vision systems, and neural network learning.

In recent demonstrations, Optimus has walked autonomously, handled delicate objects with precise dexterity, and even sorted battery components on Tesla's factory floors. CEO Elon Musk believes Optimus could one day eclipse the company's electric vehicle (EV) business, suggesting that 80% of Tesla's long-term value may come from robotics.

During Tesla's second-quarter earnings call, Musk stated, "There will probably be prototypes of Optimus 3 by the end of this year, and then scale production next year." If the company succeeds in commercializing Optimus, the implications extend far beyond enhanced vehicle production.

The robot could reshape labor economics across logistics services, warehouse manufacturing, retail environments, and even elder care. Optimus has the potential to transform Tesla from an automaker into a multi-industry technology powerhouse.

Image source: Tesla.

The bigger picture: Catalysts for 2026 and beyond
Both Nvidia and Tesla are entering 2026 with catalysts that could redefine their long-term roadmaps.

For Nvidia, upcoming GPU architectures like Blackwell Ultra and Rubin will capture Wall Street's attention, but investors should not overlook the company's growing role in quantum AI as more advanced workloads transition from theory to production. Meanwhile, Tesla's Optimus signals the dawn of scalable robotics -- an inflection point that could prove as transformative as the launch of the iPhone.

For long-term investors, the takeaway is clear: While both Nvidia and Tesla already dominate their respective industries, their boldest products may still lie ahead. Quantum computing and humanoid robotics aren't distant dreams -- they are the next trillion-dollar visions, and these two companies are leading the charge into AI's next revolutionary chapters.

Adam Spatacco has positions in Nvidia and Tesla. The Motley Fool has positions in and recommends Nvidia and Tesla. The Motley Fool has a disclosure policy.

Paramount Skydance Corporation (NASDAQ:PSKY) Discusses Strategy to Revitalize Content and Grow Streaming Market Share October 8, 2025 8:00 PM EDT

Company Participants

David Ellison - Chairman & CEO
Ashutosh Kulkarni - CEO & Executive Director

Conference Call Participants

Lucas Shaw

Presentation

Lucas Shaw

We got to start with Paramount.

Question-and-Answer Session

Lucas Shaw

You chased this company for a couple of years, if not longer. If you look at what they own, they have a bunch of cable networks that have been in decline for almost as long as I've been doing my job. They have a movie studio that is, by most metrics, the last place movie studio over the last few years and a streaming service that in terms of at least engagement is sort of in the third tier. So why were you so interested in it? What do you see in the company that investors and a lot of other potential bidders did not?

David Ellison
Chairman & CEO

Yes. No, absolutely. It's a great question. First, I just want to say we couldn't be more excited about the place that we're starting with the asset that we purchased, right? We have 80 million streaming subscribers. We have one of the best basically content libraries in existence with Paramount and CBS. And I also think you need to distinguish when you talk about the linear business, right?

There's Cable, which yes, has been a decline. But if you look at CBS, it actually is a remarkable asset. That's been #1 in primetime for 17 straight seasons, incredible sports rights, which we're growing and is still highly profitable from a cash flow perspective. And I agree with you, has not been run in the best manner for the last 15 years. And for me, that's all opportunity, an opportunity to really reignite the creative content engines to navigate

Recommended For You

Great Southern Bancorp (GSBC - Free Report) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.55 per share. This compares to earnings of $1.41 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +0.65%. A quarter ago, it was expected that this bank holding company would post earnings of $1.37 per share when it actually produced earnings of $1.72, delivering a surprise of +25.55%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Great Southern Bancorp, which belongs to the Zacks Financial - Savings and Loan industry, posted revenues of $57.84 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 0.63%. This compares to year-ago revenues of $54.97 million. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Great Southern Bancorp shares have added about 4.5% since the beginning of the year versus the S&P 500's gain of 13%.

What's Next for Great Southern Bancorp?While Great Southern Bancorp has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Great Southern Bancorp was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.41 on $56.4 million in revenues for the coming quarter and $6.15 on $229.7 million in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Financial - Savings and Loan is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, West Bancorp (WTBA - Free Report) , has yet to report results for the quarter ended September 2025. The results are expected to be released on October 23.

This holding company for West Bank is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of +34.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

West Bancorp's revenues are expected to be $24.1 million, up 18.6% from the year-ago quarter.

By Reuters

October 16, 202512:33 AM UTCUpdated ago

A view shows oil pump jacks outside Almetyevsk, in the Republic of Tatarstan, Russia July 14, 2025. REUTERS/Stringer/File Photo Purchase Licensing Rights, opens new tab

TOKYO, Oct 16 (Reuters) - Brent crude futures rose by 1.1% to $62.61 per barrel at 0012 GMT after U.S. President Donald Trump said on Wednesday that Indian Prime Minister Narendra Modi had pledged to stop buying oil from Russia.

Trump said he would try to get China to do the same as Washington intensifies efforts to cut off Moscow's energy revenues. India and China are the two top buyers of Russian seaborne crude exports.

Sign up here.

Reporting by Katya Golubkova; Editing by Jacqueline Wong

Our Standards: The Thomson Reuters Trust Principles., opens new tab

For the quarter ended September 2025, Pinnacle Financial (PNFP - Free Report) reported revenue of $544.8 million, up 16.7% over the same period last year. EPS came in at $2.27, compared to $1.86 in the year-ago quarter.

The reported revenue represents a surprise of +4.74% over the Zacks Consensus Estimate of $520.15 million. With the consensus EPS estimate being $2.05, the EPS surprise was +10.73%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Pinnacle Financial performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Efficiency Ratio: 55.6% versus 54.5% estimated by five analysts on average.Net Interest Margin: 3.3% compared to the 3.3% average estimate based on five analysts.Annualized net loan charge-offs to avg. loans: 0.2% compared to the 0.2% average estimate based on four analysts.Nonaccrual loans: $149.68 million compared to the $161.39 million average estimate based on three analysts.Total nonperforming assets: $154.89 million versus the three-analyst average estimate of $166.75 million.Average balances - Total interest-earning assets: $50.08 billion compared to the $49.69 billion average estimate based on three analysts.Total noninterest income: $147.94 million versus $126.71 million estimated by five analysts on average.Net Interest Income: $396.87 million versus $392.83 million estimated by four analysts on average.Gains on mortgage loans sold, net: $1.83 million versus $2.71 million estimated by three analysts on average.Service charges on deposit accounts: $18.29 million versus $17.46 million estimated by two analysts on average.Insurance sales commissions: $4.02 million versus $3.66 million estimated by two analysts on average.Trust fees: $10.32 million compared to the $9.47 million average estimate based on two analysts.View all Key Company Metrics for Pinnacle Financial here>>>

Shares of Pinnacle Financial have returned -2.9% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Brian Niccol, during an interview at Salesforce's Dreamforce conference, spoke about the mistake he made during his first year as CEO of Starbucks.

Eugene Gologursky/Getty Images for Fast Company

2025-10-16T00:34:05Z

Brian Niccol explained the mistake he made during his first year as Starbucks' CEO.
He said he didn't position the turnaround plan as part of the cultural conversation quickly enough.
Niccol added that leadership means hearing feedback — and being brave enough to make unpopular decisions.

Speaking on Wednesday at the Salesforce Dreamforce conference in San Francisco, Brian Niccol acknowledged that he's made a mistake during his first year as Starbucks' CEO.

"Initially, we had taken the tactic like 'hey, we just got to get this business turned around and then we'll start talking about what's going on,' and the reality is we needed to get into conversation from day one so people understood, transparently, what we are trying to do with Starbucks," Niccol told interviewer Heather Ruden, the area vice president of global field marketing at Salesforce.

Since taking the role of CEO in September 2024, Niccol has been spearheading the "Back to Starbucks" initiative — a series of major policy overhauls intended to improve the customer experience and return Starbucks to its glory as the "third place" customers spend time, other than at home and work.

It was in communicating his comeback strategy and Starbucks' role as a cultural leader that he erred in his first few months on the job, Niccol said.

"I would say, you know, early on, we needed to figure out how to tell our story again and do it in the right channels and in a culturally relevant way," Niccol said. "And I think, you know, luckily, we're now getting back to being on our front foot in talking about our business."

Starbucks' comeback campaign has encompassed everything from the dress code for baristas to streamlining the menu and overhauling the mobile ordering system. Starbucks has previously told Business Insider that customer engagement scores have increased in response to the changes.

However, Niccol has faced criticism from corporate and store-level employees about the "Back to Starbucks" plan, which has included two rounds of sweeping layoffs and the closure of hundreds of Starbucks stores in addition to the procedural changes.

Wall Street is not fully convinced about the the "Back to Starbucks" revitalization initiative; the company reported its sixth consecutive quarter of declining sales in July.

Stock for Starbucks is down more than 13% since the company announced Niccol would take the helm as CEO. It closed slightly up on Wednesday, at $82.86 per share.

The company has recently introduced its new protein cold foam menu options, capitalizing on both Gen Z's love of customizable cold drinks and the ongoing protein craze. It also activated the Swifties with a Taylor Swift-themed marketing campaign to celebrate the release of her "Life of a Showgirl" album.

When asked by Ruden about whom he has trusted to help him make decisions about Starbucks' cultural positioning, Niccol pointed to changes in the company's leadership team that have been executed since he took over as CEO, including the introduction of several staff members he had worked with before during his time as chief executive of Chipotle and Taco Bell.

He added, though, that being the company's leader means clearly outlining the plan for the company's performance, and sticking to it — even if that comes without immediate buy-in or consensus.

"If you're waiting for others to give you consent or support, you're going to be waiting for a while, because you're asking people to change — and in change is discomfort," Niccol said.

Niccol came to Starbucks after a successful stint as CEO of Chipotle, which saw sales skyrocket, and the company's share price soar more than eightfold, trading at around $6 a share when he became CEO to around $56 each by the time he left to join the coffee giant.

While at Chipotle, he executed a similar comeback strategy as the one he has introduced at Starbucks, laying off nearly 400 staff members before relocating the company's headquarters to Newport Beach, California, and shuttering more than 50 Chipotle locations identified as low performers.

Reflecting on his leadership trajectory, Niccol said he finds himself doing more listening now than he did when he was younger, and getting more "comfortable" with making decisions that "are not going to please everybody."

"I think the job of a leader is to take all that information, make a decision, galvanize everybody around that decision, and then be comfortable with moving forward," Niccol said.

He added: "You also have to then recognize that there are people that aren't comfortable with the decision, and moving forward, you're going to need to ask them to go somewhere else because, unfortunately, it just becomes a big distraction, and it really can become a cancer on your culture."

Ultimately, Starbucks "stands for more than coffee," Niccol said, and it's up to him as CEO to set the company's pace and communicate its mission and values from the top down.

Representatives for Starbucks did not immediately respond to a request for comment from Business Insider.

Have a tip? Contact this reporter via email at Katherine Tangalakis-Lippert at [email protected] or Signal at byktl.50. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely.

Starbucks

Read next

Your daily guide to what's moving markets — straight to your inbox.

Highlights: Formation has closed $8,262,389.48 in gross proceeds, fully funding its planned 20,000 metre total multi-phase drill program at its flagship N2 Gold Project in Quebec, host to a global historic resource of ~870,000 ounces comprised of 18 Mt grading 1.4 g/t Au (~809,000 oz Au) across four zones (A, East, RJ-East, and Central)2,3 and 243 Kt grading 7.82 g/t Au (~61,000 oz Au) across the RJ zone2,4 . Phase 1, consisting of 10,000 metres, commenced on September 25, 2025.

South Korea is nearing a decision on whether to allow Google and Apple to export high-resolution geographic map data to servers outside the country. The detailed maps, which use a 1:5,000 scale, would show streets, buildings, and alleyways in far greater detail than currently available on these platforms. However, several regulatory and security hurdles remain unresolved.

Earlier this week, South Korea’s National Assembly Defense Committee held a parliamentary audit of Google Korea. Lawmakers questioned the company’s requests for local map data, raising concerns over national security and digital sovereignty. The session comes two months after Seoul postponed its decision on Google’s request to export high-resolution map data in August, following an earlier delay in May.

A policymaker has warned that Google’s satellite maps could endanger national security by exposing sensitive military sites when combined with commercial imagery and online data. The lawmaker is urging the government to gain authority to monitor and regulate the export of high-resolution geographic information. Given that South Korea remains technically at war with North Korea, the government is cautious about exposing such locations.

The government’s final decision on Google Maps is expected around November 11, or possibly even earlier, a South Korean government official told TechCrunch. Last month, the Ministry of Land, Infrastructure and Transport announced it would extend the review period by an additional 60 days.

In February, Google requested, for the third time in South Korea, permission from the Korean National Geographic Information Institute to use a 1:5,000 scale map, which provides much greater details, in its app and to transfer the map data to servers outside of South Korea. Currently, Google uses a 1:25,000 scale map that includes points of interest and satellite imagery. Local navigation apps such as Naver Map, T Map, and Kakao Map are the most popular among local users. These apps offer map data at a scale of 1:5,000, and therefore, much more information and detail, giving them a significant competitive advantage.

In 2011 and again in 2016, South Korean authorities turned down Google’s request for access to the country’s map data. Officials made clear that approval would hinge on the company opening a local data center and obscuring sensitive locations, including national security sites, citing security concerns. Google declined to meet these conditions.

After South Korea rejected approval in August, Google reportedly agreed to obscure the locations of the country’s security sites on Google Maps and Google Earth. The company is blurring sensitive installations to address government concerns over satellite imagery and is reportedly exploring the purchase of government-approved satellite data from local providers, including T Map.

Techcrunch event

San Francisco
|
October 27-29, 2025

Google did not immediately respond to a TechCrunch request for comment.

Under South Korea’s Geospatial Information Management Act (Article 16), government survey data — such as maps and satellite images — cannot be sent abroad without approval from the entire Cabinet. Passed in the 1970s, the law continues to underpin the country’s strict control over geospatial data.

Map data has become a sensitive national security issue in conflict zones worldwide. The Israeli army asked Google Maps to turn off real-time traffic data in Israel and Gaza in 2023, just as it did in Ukraine after Russia’s 2022 invasion. And in 2009, European regulators had urged Google to delete original Street View images over privacy concerns.

Apple follows Google in seeking South Korea map data
It’s not just Google making moves. Apple also requested in June to export high-resolution map data from South Korea at a 1:5,000 scale. That came after its initial request in 2023 was turned down.

While Google keeps its map servers outside Korea, Apple operates local servers, a distinction the government weighs when reviewing requests. Local servers allow authorities to respond swiftly to security concerns at sensitive sites.

Last month, South Korea postponed its decision on allowing Apple to export high-precision digital map data, pushing the review to December.

Reports suggest Apple may show more flexibility than Google in adhering to government-imposed restrictions, including blurring, masking, or lowering the resolution of sensitive sites. The company is also said to plan to use SK Telecom’s T Map as its primary base map data source.

Apple did not respond to TechCrunch’s requests for comment.

Google and Apple are upgrading their maps with detailed building footprints, alleyways, and precise street-level data to enhance navigation, which could also support advanced technologies like self-driving cars and drone deliveries. For South Korea, exporting high-resolution map data could boost tourism, promote local businesses, and drive smart city innovation, while giving the government leverage to enforce security safeguards. Critics, however, warn that the move may primarily benefit U.S. tech giants rather than domestic users.

Google Maps has a broader global reach, covering 250 countries and territories, while Apple Maps is available in just over 200 regions, per a report.

Kate Park is a reporter at TechCrunch, with a focus on technology, startups and venture capital in Asia. She previously was a financial journalist at Mergermarket covering M&A, private equity and venture capital.

View Bio